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INTRODUCTION Polycystic Ovary Syndrome (PCOS) is a reproductive and endocrine 
disorder common among women of reproductive age. It is characterized by elevated 
androgen levels, menstrual irregularities, and several cysts ranging from 2 to 9 mm on 
one or both ovaries. PCOS is prevalent in approximately 10% of women typically 
between the ages of 18-44. It is significantly underdiagnosed due to variation in disease 
manifestation. Treatment for PCOS includes oral contraceptives, Metformin, and 
Spironolactone. However, supplements such as zinc and magnesium are increasingly 
promising additions to PCOS treatment regimens to manage symptoms and co-morbid 
chronic diseases. The objective of this thesis is to determine the prevalence of supplement 
use as a treatment for PCOS in the Ovulation and Menstruation Health Pilot Study (OM). 
The OM Pilot study is an epidemiological, online survey that aims to study the 
characteristics and determinants of female reproductive diseases in a diverse population. 
This thesis also explores the overall role of nutrition in PCOS management.  
 
METHODS The goal of the OM Pilot Study is to determine women’s gynecological 
health outcomes in a multi-ethnic cohort and to characterize the lifestyle, health, and 
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menstrual risks of reproductive diseases such as polycystic ovary syndrome, 
endometriosis, and uterine fibroids. The eligibility criteria included: being of 
reproductive age, having the ability to menstruate, being able to read in English, and 
having a working email address to receive the link to the survey. The survey and 
questions were designed by a board-certified reproductive endocrinology and infertility 
specialist at Boston Medical Center and was administered through REDCap, a cloud-
based clinical software application for building and managing online surveys and 
databases. The questionnaire was comprised of each of the following sections: 
Demographics, Baseline Questionnaire, Anthropometrics, Menstrual Cycle, 
Contraceptive History, Health and Body, Polycystic Ovary Syndrome, Reproductive 
Health Questions, General Health Questions, Diet and Lifestyle, and Pregnancy and Birth 
History. Participants were recruited from multiple cities across the United States using in-
person recruiting methods, online recruitment through a link, flyers, posters, word-of-
mouth, and advertisements on Facebook and other social media websites such as Twitter 
and LinkedIn. Consenting participants were entered into a raffle to win a $200 gift card. 
Data analysis was conducted on SAS 9.4 and manually as needed.  
 
RESULTS In terms of prevalence of PCOS: Of the 249 women who completed the 
survey, 60 women self-reported to having polycystic ovary syndrome (37 were diagnosed 
by a physician and 23 diagnosed by self). And of those 60 women who reported having 
PCOS, 24 reported taking medication for PCOS and out of these women, 10 women 
reported taking one, two, or three of the supplementary treatment options. Of the 60 
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women with PCOS, 4 women currently take a multivitamin for PCOS, 2 women 
currently take a dietary supplement, 2 women currently take herbal remedies, and 4 
women reported drinking spearmint tea to help with PCOS management. Additionally, 
out of the 60 women who reported yes to having PCOS whether they were diagnosed by 
a physician and self-diagnosed, 11 women also reported yes to having an eating disorder. 
Of those 11 women, 7 women have anorexia, 7 women have bulimia, and 4 women have 
binge eating disorder.  
 
CONCLUSION In this thesis, the prevalence rates of PCOS diagnoses, supplement use 
among PCOS patients, and eating disorders among PCOS patients were determined. 
Based on current literature on the effectiveness of supplements on PCOS symptoms, it 
seems advisable to study the effects of supplements further to incorporate them into 
treatment. With additional research, medical personnel such as physicians and registered 
dietitians should consider adding supplements to treatment regimen for PCOS. A 
personalized diet and exercise plan along with a plan to treat mental health to curb the 
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Polycystic Ovary Syndrome: Disease and Symptoms 
Polycystic Ovary Syndrome (PCOS) is a reproductive, endocrine, and metabolic 
disorder affecting women of reproductive age and is characterized by elevated androgen 
levels, menstrual irregularities, and several cysts ranging from 2 to 9 mm on one or both 
ovaries (Ndefo et al., 2013). The prevalence of PCOS is approximately 10% in women of 
reproductive ages, 18-44 and is significantly underdiagnosed due to variation in disease 
manifestation (Wolf et al., 2018). However, prevalence of PCOS varies within race and 
ethnicity with lowest incidence rates in Chinese (5.6%) and White women (4.8%) and 
highest in Black women (8%) (Ding et al., 2017). 
The signs and symptoms of PCOS include enlarged ovaries with cysts, irregular 
menstrual cycles, pelvic pain, hirsutism, alopecia, acne, acanthosis nigricans (skin 
discoloration), and skin tags (Ndefo et al., 2013). Moreover, comorbidities such as 
obesity, type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease are 
prevalent in women with PCOS (Ali, 2015). 
PCOS is now clinically diagnosed using a criteria created and modified by the 
National Institute of Child Health and Human Development (NICHD), the European 
Society of Human Reproduction and Embryology (ESHRE), and the American Society 
for Reproductive Medicine (ASRM) (Ndefo et al., 2013). The current diagnostic criteria 
require 2 of the 3 following symptoms to classify a condition as PCOS: 
hyperandrogenism, oligo-ovulation or anovulation, and polycystic ovaries as determined 
by an ultrasound.  
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Due to the variation in PCOS manifestation, the disease was divided into 4 
phenotypes by the Rotterdam criteria in 2004 (Table 1): 1) frank or classic PCOS 
(chronic anovulation, hyperandrogenism, and polycystic ovaries), 2) classic non-
polycystic PCOS (chronic anovulation, hyperandrogenism, and normal ovaries), 3) non-
classic ovulatory PCOS (regular menstrual cycles, hyperandrogenism, and polycystic 
ovaries), and 4) non-classic mild or normoandrogenic PCOS (chronic anovulation, 
normal androgens, and polycystic ovaries) (El Hayek et al., 2016), Rotterdam 
ESHRE/ASRM-Sponsored PCOS consensus workshop group, 2004).  
 
Table 1. The Four Phenotypes of polycystic ovary syndrome (PCOS) as concluded 
by Rotterdam in 2004 (El Hayek et al., 2016). 
Phenotypes Symptoms 
1: Frank or Classic PCOS chronic anovulation, hyperandrogenism, and 
polycystic ovaries 
2 Classic non-polycystic PCOS chronic anovulation, hyperandrogenism, and 
normal ovaries 
3 Non-classic ovulatory PCOS  regular menstrual cycles, hyperandrogenism, and 
polycystic ovaries 
4 Non-classic mild or 
normoandrogenic PCOS 






Pathophysiology of PCOS 
The pathophysiology of PCOS involves hyperandrogenism, hyperinsulinemia, 
chronic inflammation caused by oxidative stress, and epigenetic factors (El Hayek et al., 
2016). Additional dysfunction includes abnormalities in hypothalamic-pituitary axis, 
ovarian function, and insulin regulation (Ndefo et al., 2013). Elevated luteinizing 
hormone (LH) and gonadotropin-releasing hormone (GnRH) levels and reduced 
follicular-stimulating hormone (FSH) levels are clinical signs of PCOS that describe 
ovarian dysfunction. The increased levels of GnRH over-stimulate ovarian thecal cells 
that produce androgens, hence causing hyperandrogenism (Ndefo et al., 2013). 
Hyperandrogenism is elevated androgen levels caused by dysfunction in the 
hypothalamic-pituitary-ovarian or adrenal axis that ultimately affects fertility through 
hormonal imbalance (Morgante et al., 2015). The most common pharmacological 
treatment for hyperandrogenism is oral contraceptive pills, whose function is to decrease 
LH secretion via negative feedback resulting in decreased androgen synthesis (Badawy & 
Elnashar, 2011). Some vitamin, mineral, and other supplements that may play a role in 
directly mitigating hyperandrogenism include vitamin A, Inositol, vitamin D, 
bioflavonoids, carnitine, calcium, selenium, zinc, melatonin, n-acetyl-L-cysteine, omega-




Figure 1: Pathophysiology of PCOS: Hyperandrogenism  
(Legend: Blue arrows represents agonist activity and red arrow represents inhibitive activity)  
 
Hyperinsulinemia caused by insulin resistance and general glucose 
dysmetabolism can lead to obesity, glucose intolerance, and increased risk of diabetes 
mellitus and cardiovascular disease (Rojas et al., 2014). Vitamin, mineral, and other 
supplements that affect the pathophysiology of hyperinsulinemia include vitamin A, 
vitamin B, inositol, vitamin D, vitamin E, alpha-lipoic acid, bioflavonoids, carnitine, 
calcium, chromium, magnesium, selenium, zinc, n-acetyl-l-cysteine, omega-3 fatty acids 






Figure 2: Pathophysiology of PCOS: Hyperinsulinemia    
(Legend: Blue arrows represents agonist activity and red arrow represents inhibitive activity)  
 
 
PCOS Treatment and Supplements 
Treatment goals for PCOS typically correct anovulation, androgen excess, and/or 
insulin resistance which present a wide variety of options for treatment. A common 
nonpharmacological treatment for PCOS is surgical intervention such as laparoscopic 
ovary drilling, a procedure where an electrocautery or laser is used to remove androgen 
producing tissue on the ovaries to trigger ovulation. This surgical intervention is typically 
used when medication is not effective in patients and/or patients are allergic to pertinent 
medication (Felemban et al., 2000).  
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Pharmacological approaches to PCOS treatment include menstrual cycle 
regulating oral contraceptive pills, ovulation inducing Clomiphene, antidiabetic agents 
such as Metformin, ovulation promoting artificial hormones and enzymes such as 
gonadotropins and aromatase inhibitors, androgen decreasing Spironolactone, uterine 
bleeding amenorrhea controlling Medroxyprogesterone acetate, and testosterone reducing 
statins (Ndefo et al., 2013).   
Supplements, in general, are a widely studied addition to any numerous diseases 
as well overall well-being. Similarly, supplements have been a popular addition to the 
PCOS treatment regimen due to their role in intervening with the pathology of PCOS at a 
molecular level and potentiating the regulation of dysfunctional pathways. The most 
commonly prescribed supplements for PCOS treatment are: vitamin A, vitamin B, 
Inositol, vitamin D, vitamin E, alpha-lipoic acid, bioflavonoids, carnitine, calcium, 
chromium, magnesium, selenium, zinc, melatonin, n-acetyl-L-cysteine, omega-3 fatty 
acids, and probiotics (Günalan et al., 2018, Arentz et al., 2017).  
Tables 2a, 2b, and 2c describe the most commonly used supplements for PCOS 
and their intended effects. Majority of the intended effects focus on reducing the effects 
of hyperandrogenism and hyperinsulinemia while some are involved in multiple 
metabolic pathways in the PCOS pathophysiology. The anti-inflammatory and pro-
inflammatory effects contributing the overall detrimental oxidative stress due to reactive 




Table 2a. Most Commonly Used Supplements for PCOS and intended effects: 
Vitamins (Günalan et al., 2018).  
Supplement Studied 
Effect 
Hyperandrogenism Hyperinsulinemia Other 
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Table 2b. Most Commonly Used Supplements for PCOS and intended effects: 
Minerals (Günalan et al., 2018).  
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Table 2c. Most Commonly Used Supplements for PCOS and intended effects: Other 
(Günalan et al., 2018).  
Supplement Studied Effect Hyperandrogenis
m 
Hyperinsulinemia Other 
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PCOS and Chronic Disease 
50-70% of women with PCOS have insulin resistance as a co-morbidity. As a 
result, these women also have a higher risk, approximately 5 to 10 fold, of developing 
glucose intolerance and type 2 diabetes mellitus (Ibricevic & Avsimi, 2013, Pelusi et al., 
2004). They also tend to have an increased risk due to the following additional co-
morbidities: obesity, insulin resistance (hyperinsulinemia, decreased peripheral insulin 
sensitivity), beta-cell dysfunction, chronic anovulation, family history, and dyslipidemia 
(Legro, 2001).  
While treatment with Metformin is common, supplements such as vitamin (A, D, 
E, B), chromium, and magnesium are recommended to curb the factors contributing to 
glucose dysmetabolism (Günalan et al., 2018, Yilmaz et al., 2017). Similarly, the risk 
factors associated with diabetes such as hyperlipidemia and obesity also contribute to the 
development of metabolic syndrome and cardiovascular disease (Charlton, 
2009). Moreover, women with PCOS that have higher BMI and central fat accumulation 
are at a higher risk for both diabetes and cardiovascular disease (Ibricevic & Avsimi, 
2013). 
 
PCOS, Eating Disorders, and Overall Nutrition 
Given the nature of glucose dysmetabolism and general insulin resistance, weight 
gain is often an unwanted effect (Erion & Corkey, 2017). Although one can manage 
excessive weight gain through a well-balanced diet and regular exercise, some weight 
gain is inevitable and difficult to prevent due to hormonal changes (Clamp et al., 2017). 
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One of the consequences of this weight gain is the increased risk of disordered eating (da 
Luz et al., 2018). The overall role of nutrition including adequate diet, exercise, and 
general healthy habits such as maintaining strong interpersonal relationships in PCOS 
symptom management is an important discussion between clinician and patient. 
 
Ovulation and Menstruation Health Pilot Study 
The Ovulation and Menstruation Health (OM) Pilot Study is an epidemiologic, 
online survey conducted by the Mahalingaiah Laboratory at Boston University Medical 
Campus that aimed to collect health and lifestyle characteristics of a multiethnic sample 
to see if it would be feasible to create a database for assessing the health risk of PCOS in 
the population. Women of reproductive age, who have the ability to menstruate, and have 
an email address are eligible for the OM Pilot study. Women who consent and screen into 
the study are asked questions regarding their medical history, family history, lifestyle, 
and menstruation health history. The goal of the OM Pilot study is to analyze a multi-
ethnic cohort for various determinants of female reproductive health. 
The objective of this thesis is to determine the prevalence of supplement use as a 













This thesis project aims to determine the prevalence of supplement use as a treatment in 
women with polycystic ovary syndrome in the Ovulation and Menstruation Pilot Study.  
 
The Specific Aims of this thesis are as follows: 
1. To determine the prevalence of vitamins, supplements, and herbal remedies use 
among women with PCOS in the Ovulation and Menstruation Pilot study 
2. To study the role and importance of nutrition in PCOS 
a. Determine prevalence of eating disorders among women with PCOS 
b. Determine healthy diet and lifestyle behaviors 




METHODS AND MATERIALS 
 
The Ovulation and Menstruation Health Study  
 
The Ovulation and Menstruation Health Pilot Study is an online epidemiologic 
survey that aims to determine women’s reproductive health outcomes in a multi-ethnic 
cohort. The goal of the study is to characterize the lifestyle, health, and menstrual risks of 
reproductive diseases such as polycystic ovary syndrome, endometriosis, and uterine 
fibroids. The eligibility criteria included: to be of reproductive age, have the ability to 
menstruate, be able to read in English, and have a working email address to receive the 
link to the survey. The exclusion criteria included participants below 18 years, people 
who identified as male, people who were pregnant at the time of the survey, history of 
hysterectomy, people who had been exposed to radiation or chemotherapy, and people 
who are unable to provide a working email address.  
The survey and questions were designed by a board-certified reproductive 
endocrinology and infertility specialist at Boston Medical Center (BMC). The survey was 
an online questionnaire conducted through REDCap, a cloud-based clinical software 
application for building and managing online surveys and databases. The questionnaire 
was designed in English at an 8th grade reading level and was tested (cognitive pre-
testing) for validity and usability for a diverse population (Mahalingaiah, 2020).  
The questionnaire was comprised of each of the following sections: 
Demographics, Baseline Questionnaire, Anthropometrics, Menstrual Cycle, 
Contraceptive History, Health and Body, Polycystic Ovary Syndrome, Reproductive 
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The participants were recruited using a two-minute informational video (in English 
and Spanish) about women’s reproductive health with emphasis on menstrual cycle posted 
on the OM Pilot study website. Participants were also recruited from multiple cities across 
the United States using in-person recruiting methods, flyers, posters, word-of-mouth and 
advertisements on Facebook and other social media websites such as Twitter and LinkedIn. 
Consenting participants were entered into a raffle to win a $200 gift card.  
Participants were recruited in person at BMC in Boston, Massachusetts from 
September 11, 2017 to October 23, 2017 by the OB/GYN department chair and physicians. 
Recruitment letters with a link to the survey were sent to patients and were asked to reply 
via email if they were willing to participate in the OM Pilot study.  
Additionally, participants were recruited at a Community Fair Event at the Boston 
Women’s Market in Jamaica Plain on September 17, 2017. Interested participants were 
asked to complete a consent form and screener information on an electronic tablet. Eligible 
participants were sent a link to the survey.  
 
PCOS Diagnosis and Variables  
 
To determine the prevalence of PCOS, women in the OM cohort were asked 
questions regarding diagnosis of PCOS (Table 3). Women with PCOS were either 
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diagnosed by a physician or by self-assessment. For this thesis, both categories will be 
merged as one, PCOS diagnosis.  
 
 








diagnosed by a 
physician  
Polycystic Ovary Syndrome is a health condition involving 
irregular periods, excess testosterone, increased acne, body and 
facial hair, and many small cysts on the ovaries. Some women also 







Do you think you might have PCOS? 
 
To determine the prevalence of medication and supplement use, women in the 
OM cohort were asked about their consumption of either or both (Table 4). Medications 
usage was assessed by asking about the most common pharmacological treatment. 
Supplement questions included three categories: vitamin, dietary, and herbal remedies. 












Table 4.  Questions in the survey to determine prevalence of medication and 
supplement use among those with PCOS.  
  
Medication Use 
 Have you ever taken any medicines to treat PCOS? Metformin, Oral, 
Contraceptives, Spironolactone, Other (Aygestin, Letrozole, Spiro+ 
laser hair removal, electrolysis, and Vaniqua) 
 
 Are you currently taking any medicines to treat your PCOS? Oral 
contraceptive pills, Metformin, Spironolactone, Other 
 
Supplement Use 
Vitamin Do you currently take a multivitamin designed for PCOS?  
 Have you ever taken any vitamins, supplements, or herbal remedies 
designed to specifically treat PCOS?  
Dietary Do you currently take any dietary supplements to help with PCOS 
symptoms? Fish oil, Omega-3 Fatty Acids, Myoinositol, Protein 




Do you currently take any herbal remedies to help with PCOS related 
symptoms? Echinacea, Gingko biloba, St. John’s Wort, Kava Kava  
 
Other  Do you drink Spearmint tea to help with PCOS?  
 
 
To determine the prevalence of eating disorders among the whole OM population 
and within women with PCOS, women in the OM cohort were asked questions about 
their history with eating disorders as well as the type of eating disorder (Table 5). The 







Table 5. Questions in the survey to determine to prevalence of eating disorders 





Have you ever had an eating disorder? 
 
  
Type of Eating 
Disorder 
If yes, what eating disorders have you been diagnosed with? Anorexia 
Nervosa, Bulimia, Binge Eating  
 





Data analysis  
 
For data collection, management, and analysis of the Ovulation and Menstruation 
















OM Pilot Study Description  
 
After relevant recruitment strategies were implemented, 283 women started the 
survey and 249 women completed the survey from baseline to the end. The mean age of 
this population was 27.7 years old. Among the 283 women, 198 (70%) were White, 30 
(10.6%) were Hispanic, Latina, or of Spanish origin, 35 (12.4%) were Black or African 
American, 10 (3.5%) were East Asian, 9 (3.2%) were Southeast Asian, 8 South Asian 
(2.8%), 5 (1.8%) were American Indian or Native American, 4 (1.4%) were Middle 
Eastern, 1 (0.4%) was Native Hawaiian or Pacific Islander, and 5 (1.8%) are some other 
race, ethnicity, or origin (Table 6).  
In terms of education level, of the 283 women, 1 (0.4%) reported 8th grade or less, 
1 (0.4%) reported some high school/did not graduate, 19 (6.7%) reported high school 
graduate/GED, 38 (13.4%) reported some college or 2-year degree, 101 (35.7%) reported 
4-year college graduate, and 115 (40.6%) reported more than 4-year college degree. 8 
women were categorized as having missing data.  
In terms of income level, of the 283 women, 29 (10.2% reported making below 
$15,000, 29 (10.2%) reported making $15,000-$24,999, 71 (25.1%) reported making 
$25,000-$49,999, 46 (16.3%) reported making $50,000-$74,999, 20 (7.1%) reported 
making $75,000-$99,999, 15 (5.3%) reported making $100,000-$124,999, 4 (1.4%) 
reported making $125,000-$149,999, 9 (3.2%) reported to making $150,000-$199,999, 
and 15 (5.3%) reported making $200,000 or more. 8 women were categorized as having 





Table 6. Ovulation and Menstruation Cohort population demographics.  
Characteristics  N  
Number of Participants  283 
Mean Age  27.7  
 
Race N  % 
White 198 70 
Hispanic, Latina, or Spanish Origin 30 10.6 
Black or African American 35 12.4 
East Asian 10 3.5 
Southeast Asian 9 3.2 
South Asian 8 2.8 
American Indian or Native 
American 
5 1.8 
Middle Eastern  4 1.4 
Native Hawaiian or Pacific 
Islander  
1 0.4 
Other or Multiple Race/Ethnicity 5 1.8 
 
Education Level N  % 
8th grade or less 1 0.4 
Some high school, did not graduate 1 0.4 
High school, graduate, or GED 19 6.7 
Some college or 2-year degree  38 13.4 
4-year college graduate  101 35.7 
More than 4-year college degree  115  40.6 
Missing  8 2.8 
 
Income Level  N  % 
Below $15,000 29 10.2 
$15,000 - $24,999 29 10.2 
$25,000 - $49,999 71 25.1 
$50,000 - $74,999 46 16.3 
$75,000 - $99,999 20 7.1 
$100,000 - $124,999 15 5.3 
$125,000 - $149,999 4 1.4 
$150,000 - $199,999 9 3.2 
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$200,000 or more  15 5.3 






Of the 283 women who started the survey, 249 women completed the survey, 
answering questions about reproductive health, especially PCOS. Of those 249 women, 
60 reported having polycystic ovary syndrome and of those 60, 37 were diagnosed by a 
physician and 23 were self-diagnosed. These results are summarized in Table 7.  
 
Table 7. PCOS Status as diagnosed by physician or by self.   
  
Physician 
 n % 
Yes 37 13 
No 219 77.4 
Missing 27 9.5  
Self 
Yes 23 8.1 
No 196 69.3 
Missing 27 9.5 
Total N 283 
 
 
Women with PCOS are generally prescribed oral contraceptives, Metformin, 
Spironolactone, etc. or a combination for PCOS symptoms (Legro, 2000). Of the 60 
women who have reported to having PCOS, 24 have taken medication for PCOS (Table 
8). 11 women have taken Metformin, 19 have taken oral contraceptives, and 4 have taken 
Spironolactone. 3 women have reported to taking other medication including Aygestin, 
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Letrozole, laser hair removal, electrolysis, and Vaniqua (Eflornithine). These results are 
summarized in Table 8.  
 
Table 8. Medication use among women with PCOS.  
Medication Use n % 
Have you ever taken any 
medicines to treat PCOS? 
  
Yes 24 8.5 
No 13 4.6 
Missing 27 9.5 
Total 54 
   
What medicines have you ever 
taken to treat PCOS? 
  
Metformin 11 3.9 
   
Oral Contraceptives 19 6.7 
   
Spironolactone 4 1.4 
   
Other (Aygestin, Letrozole, 
laser hair removal, 




Women with PCOS were asked if they take vitamins, supplements, or herbal 
remedies specifically to treat PCOS (Table 9). 10 women have reported yes to taking one, 
two, or three of the supplementary treatment options. Four women said they currently 
take a multivitamin for PCOS, 2 women currently take a dietary supplement, and 2 
women currently take herbal remedies. Additionally, 4 women reported to drinking 







Table 9. Supplement Use Among Women with PCOS in the OM Pilot Study.  
 n % 
Have you ever taken any 
vitamins, supplements, 
or herbal remedies 
designed to specifically 
treat PCOS? 
  
Yes 10 3.5 
No 50 17.7 
Missing 27 9.5 
Total 60  




Yes 4 1.4 
No 6 2.1 
Missing 27 9.5 
Total 60  
Do you currently take 
any dietary supplements 
to help with PCOS 
symptoms?  
  
Yes 2 0.7 
No 8 2.8 
Missing 27 9.5 
Total 60  
Fish oil, Omega-3 Fatty 
Acids 
2 0.7 




Probiotics 1 0.4 
Prebiotics 0 0 
Other  2 0.7 
Do you currently take 
any herbal remedies to 
help with PCOS related 
symptoms? 
  
Yes 2 0.7 
No 8  
Missing 27  
 
28 
Total 60  
Echinacea 1 1 
Ginko biloba 0 2 
St. john’s Wort  0 2 
Kava Kava  0 2 
Do you drink Spearmint 
tea to help with PCOS? 
4 56 
Yes 4 1.4 
No 56 19.8 




Participants who reached the Eating Disorder section of the OM Pilot Study were 
asked if they ever had an eating disorder including anorexia nervosa, bulimia, and binge 
eating. 35 women reported that they have had an eating disorder. Of those 35 women, 17 
reported that they had anorexia, 14 reported they had bulimia, and 19 reported they had 
binge eating disorder (Table 10).  
 
Table 10. Eating disorders in OM Pilot Study.  
 N  % 
Have you ever had an 
eating disorder? 
  
Yes 35 12.4 
No 216 76.3 
Missing 32  
Total   
If yes, what eating 
disorder have you been 
diagnosed with?  
  
Anorexia 17 6.0 
Bulimia  14 4.9 




Of the women who have PCOS, whether they were diagnosed by a physician and 
self-diagnosed (Table 1), 11 women reported yes to having an eating disorder. Of those 
11 women, 7 women had anorexia, 7 women had bulimia, and 4 women had a binge 
eating disorder (Table 11).  
 
Table 11. Eating Disorders among women with PCOS. 
 n  % 
Have you ever had an eating disorder?   
Yes 11 18.3 
No 47 78.3 
 
Total 
60   
If yes, what eating disorder have you 
been diagnosed with?  
  
Anorexia 7 63.6 
Bulimia  7 63.6 



















Prevalence of PCOS in OM 
As compared to the majority of research studies which predominantly consist of 
Caucasian/White women, the OM population included 10 different races/ethnicities 
including mixed race among various socioeconomic, education, and income level statuses 
(Table 6). Studying this largely varied population allows us to pinpoint the social, 
lifestyle, and health determinants of PCOS as well as analyze and determine relationships 
and associations among relevant variables. Moreover, the difference and significance of 
the prevalence rates of PCOS between the OM and US population can be further studied.   
The prevalence of PCOS within the Ovulation and Menstruation population is 
21.2%. This is nearly twice the prevalence of PCOS in the general population in United 
States, which is estimated to be 10% (Wolf et al., 2018). This higher prevalence rate 
could be attributed to any number of determinants addressed in the OM Pilot Study but 
recruiting from a predominantly OB/GYN clinical setting with participants who may 
already have the disease of interest at a disproportionate rate may explain the higher 
prevalence. 
Medication use for PCOS  
Pharmacological medication acts as the first line of defense against the symptoms 
for PCOS. Oral contraceptives or the combined oral contraceptive pill (COCP) is the 
most common medication prescribed for the management of hormonal and clinical 
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features of PCOS such as hyperandrogenism and menstrual irregularity (Teede et al., 
2019). Metformin is typically prescribed to counteract the effects of hyperinsulinemia by 
improving the sensitivity of peripheral tissues to insulin (Lashen, 2010). Spironolactone 
is an antiandrogen that is prescribed to minimize the effects of hyperandrogenism 
(Badawy & Elnashar, 2011). For those patients that cannot tolerate medication due to 
severe side effects or not seeing effective results, non-pharmacological options such as 
laparascopic ovary drilling surgery, is available. However, the risks are higher in such 
procedures (Mitra et al., 2015). 
In the OM Pilot study, the frequency of participants who take some form of 
medication for PCOS is 8.3%. Mostly commonly used medications in this cohort are oral 
contraceptives with 6.7%, followed by Metformin with 3.9%. Because the data in this 
cohort reflects that of the general population in terms of common usage of PCOS 
medication, studying the supplement use in the OM population can allow for 
generalizability when considering including supplements as an additional or alternative 
option to medication.  
PCOS supplements and pathways 
Vitamin, dietary, and herbal supplements are recommended by some physicians 
as an addition to medication for the treatment of PCOS. Due to the varied manifestation 
of symptoms and consequent chronic disease, patients are prescribed a unique 
combination of supplements to include in their treatment (Arentz et al., 2017, Badawy & 
Elnashar, 2011). The metabolic pathways that supplements such as zinc, magnesium, and 
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alpha-lipoic acid interact with are involved in PCOS-associated symptoms such as 
hyperandrogenism, menstrual cycle irregularity, and hyperinsulinemia. The specific 
pathways could be endocrine, gynecological, cardiac, or physiological and may include 
insulin resistance, oxidative stress, DNA replication and processing, and production of 
sex hormones (El Hayek et al., 2016).  
According to existing literature, the following supplements are recommended for 
PCOS due to evidence of minimizing PCOS symptoms or preventing chronic disease 
associated with PCOS: vitamin A, vitamin B (group), Inositol, vitamin D, vitamin E, 
alpha-lipoic acid, bioflavonoids, carnitine, calcium, chromium, magnesium, selenium, 
zinc, melatonin, n-acetyl-L-cysteine, omega 3 fatty acids, and probiotics (Günalan et al., 
2018).  
 
PCOS Supplements and their Intended Effects: Vitamins, Minerals, and Other  
 
Vitamins Vitamin A acts as an antioxidant to counteract the effects of oxidative stress. It 
regulates steroid metabolism and oocyte nuclear maturation, and inhibits cell apoptosis.  
Vitamin B6, B12, and folic acid are involved in the regulation of homocysteine, an amino 
acid associated with cell and tissue growth. Low levels of vitamin B can result in high 
levels of homocysteine, which is positively correlated with development of insulin 
resistance (Loverro et al., 2002, Badawy et al., 2007). Furthermore, women who take 
Metformin to treat PCOS are at a higher risk of vitamin B12 deficiency because 
Metformin inhibits vitamin B12 binding intrinsic factor in the gut and leads to decreased 
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or malabsorption (Liu et al., 2014). As such, women with PCOS should discuss adding a 
regiment of vitamin B12 supplements to Metformin. 
Although vitamin D plays a role in insulin and triglyceride regulation, its main 
role in calcium and bone health makes it a crucial supplement to add to treatment 
regimen given that vitamin D levels are lower in obese patients with insulin resistance, a 
manifestation of PCOS. Moreover, vitamin D has anti-inflammatory properties that 
contributes to the overall improvement of PCOS symptoms (Mousa et al., 2016). Studies 
show that vitamin E acts as a free radical scavenge and supplementation with this vitamin 
leads to improvement in insulin resistance and excess androgen levels (Mohammadi, 
2019).   
 
Minerals Calcium levels are lower in women with PCOS especially in those who are 
obese. Calcium in conjunction with vitamin D are essential for bone health as well as 
multiple crucial metabolic pathways from muscle movement to follicular development. 
Chromium is an essential mineral involved in the regulation of carbohydrate and lipid 
metabolism and is lower in patients with PCOS leading to insulin resistance. Because 
chromium deficiency leads to glucose dysregulation, chromium supplementation for 
PCOS patients with hyperinsulinemia is recommended.  
Magnesium is a key player in ATP (main source of energy) reactions and overall 
cell health. PCOS symptoms such as insulin resistance cause reduction in cellular 
magnesium. Selenium is an antioxidant involved in embryonic gonadal development. 
Decreased levels of selenium can lead to the accumulation of free radicals. These free 
 
34 
radicals are associated with increased androgen and testosterone levels in women with 
PCOS.  
Zinc is an essential component of many metabolic pathways in the human body. It 
is particularly important in insulin metabolism. Zinc deficiency can lead to glucose 
intolerance and diabetes. In addition to circadian rhythm regulation, melatonin also has a 
role in improving oocyte function in follicular fluid. 
 
Other Similarly, inositol, or myo-inositol, is a sugar alcohol involved in regulation of 
insulin sensitivity, lipid synthesis, signal transduction, oocyte maturation, oogenesis, cell 
morphogenesis, and cytoskeleton organization (Günalan et al., 2018). Inositol improves 
insulin levels and decreases androgen levels (Unfer et al., 2012). Alpha-lipoic acid, 
another free radical scavenger, is shown to improve menstrual irregularity, ovarian cysts, 
and overall hormonal imbalance. Bioflavonoids are anti-inflammatory and have a role in 
reducing insulin resistance. 
Carnitine, a compound active in oxidative stress mechanism and glucose 
metabolism, is found to be lower in women with PCOS, which is associated with 
hyperandrogenism and insulin resistance. For women with PCOS, melatonin supplements 
may help increase pregnancy rates. N-acetyl-L-cysteine (NAC), a precursor to 
glutathione, is an antioxidant that regulates insulin secretion from pancreatic beta cells. 
Therefore, NAC supplements taken with Metformin can help affect insulin resistance as 
well as improve overall menstrual regularity due to its effects on oocyte quality. Omega 3 
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fatty acids include polyunsaturated fatty acids, α-linolenic acid, eicosapentaenoic acid, 
and docosahexaenoic acid and are involved in lipid regulation.  
However, due to the antioxidant nature of these omega 3 fatty acids, consumption 
can lead to decreases in testosterone, hypertension, and overall improvement in lipid 
profiles which can aid in improving insulin resistance. Probiotics promote the growth of 
beneficial bacteria in the gut microbiota and are anti-inflammatory in nature. Therefore, 
probiotic supplements can improve glucose dysregulation as well the PCOS symptoms 
caused by oxidative stress.  
Although treatment for PCOS is proven to be effective, supplementing with 
vitamins and minerals can help target the pathological pathways of disease and not just 
symptoms. Some physicians and medical personnel such as registered dietitians modify 
their recommendations based on practical evidence and patient needs. For instance, one 
practicing registered dietitian in Boston, MA includes alpha-lipoic acid, berberine, 
cinnamon, co-enzyme Q10, fish oil, inositol, magnesium, melatonin, n-acetyl-cysteine, 
probiotics, vitamin D, and zinc in their recommendations for PCOS patients. In this 
Boston clinic, supplements are used either as an alternative option to medication or an 
addition to current treatment regimen. However, a strict, personalized diet along with a 
suggested exercise plan is included in this treatment regimen. Studying the population in 




 A combination of these supplements is claimed to promote normal insulin 
production, lower androgen levels, lower lipid levels, improve fatty liver, mood support, 
fertility support, lower inflammation, support gut health, reduce risk for gestational 
diabetes, promote normal blood pressure, and promote menstrual regulation. Although it 
would be difficult to pinpoint the actual effect of each supplement in each patient, 
suggesting adding one or more supplements would be beneficial for treating PCOS 
symptoms. One would have to consider the side effects of these supplements and then 
weight the benefits and detriments to determine whether or not a patient should be 
advised to take a certain supplement.  
Approximately 16.7% of participants with PCOS in the OM Pilot Study use 
supplements recommended for PCOS. Due to the nature of the questions asked in the OM 
survey, it is not known what supplements are used. Assuming that the supplements 
specifically designed for PCOS include the above discussed substances and given that 
almost 20% of patients rely on supplements, it may be worthwhile to study the effects of 
supplements in the OM cohort. However, to better understand the effects of these 
supplements in the OM Pilot Study, specific questions about supplements should be 
added to the survey.  
Eating Disorders and Nutrition in OM and PCOS 
In addition to medication and supplements, diet and lifestyle factors are crucial in 
PCOS management. It is important to study the overall role of nutrition in PCOS as it 
could help manage symptoms while also preventing chronic disease. A well-balanced diet 
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and exercise can help offset the effects of PCOS symptoms. Diets should focus on high-
fiber and low saturated fat foods (Marsh & Brand-Miller, 2005). Less emphasis should be 
placed on diets focused on counting calories as these can contribute to the development 
of eating disorders (Romano et al., 2018). 
While 12.4% of the entire OM population reported to having an eating disorder, 
18.3% of the PCOS population within the OM cohort reported to having an eating 
disorder. As this suggests an increased risk of eating disorders such as anorexia nervosa 
and binge eating among women with PCOS a personalized diet and exercise plan may be 
beneficial in treatment of PCOS (Bernadett & Szemán-N, 2016, Krug et al., 2019). 
Although the mechanisms between disordered eating and PCOS are unsettled, 
hyperandrogenism, hyperinsulinemia, and dissatisfaction with appearance, especially 
with weight gain are considered contributing factors leading to eating disorders (Love et 
al., 2016). 
The prevalence of eating disorders is significantly higher among those with PCOS 
(18.3%) when compared to entire OM Pilot population (12.4%). One potential way to 
address eating disorders is to manage the PCOS symptoms related to weight gain. For 
example, hyperinsulinemia can lead to weight gain. Thus, treating this through 
medication and supplements can potentially reduce the risk of eating disorders.  
Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis: 
Table 12 discusses the strengths and weaknesses as well as future directions for 
the OM Pilot Study. Although the OM Pilot study included women of various 
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races/ethnicities, education levels, and income levels, the majority of the population, 198 
(70%), was White and 115 (40.6%) have a graduate degree. This introduces a sampling 
bias overrepresenting those who are in good health and who are more willing to 
participate in such studies (Fisher et al., 2018).  Other weaknesses in the OM Pilot Study 
include vagueness in questions about supplements and missing data due to survey fatigue 
or other reasons. 
One of the strengths of the OM Pilot Study is diversity in race/ethnicities, 
education levels, and income levels which allows further studies about determinants of 
reproductive diseases. Other strengths include high validity of the survey as cognitive 
testing was conducted and the generalizability to general population since the cohort is 
more diverse and roughly represents the US population.  
Future directions for the OM Pilot Study could include expansion of some of the 
question sections. The medication section could also expand to include questions about 
specific supplements. Diet and Lifestyle questions could be expanded to ask about 
exercise and specific food consumption. Specific nutrition information can be collected 
through food frequency questionnaires or daily food diaries. This would allow for 
studying stronger associations between nutrition and PCOS as well as other reproductive 
diseases.  
Because there is solid evidence for direct effects of supplements on the 
pathophysiology of PCOS, physicians and other pertinent medical personnel can research 
further to include supplements in the PCOS treatment regimen along with diet and 
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exercise plans. However, because the effects of the supplements are complex, it would be 
hard to have a standard supplement treatment plan. The plans would have to be 
personalized and tailored to each patient’s needs.  
Table 12. SWOT (strengths, weaknesses, opportunities, and threats) Analysis of the 
OM Pilot Study.  
Strengths Weaknesses Opportunities Threats 






















• Need more 

























The goal of the OM Pilot was to study the characteristics of female reproductive 
diseases among a diverse population. In this thesis, the prevalence rates of PCOS 
diagnoses, supplement use among PCOS patients, and eating disorders among PCOS 
patients were determined. Based on the results from the OM Pilot Study and current 
literature, it seems advisable to integrate supplements into treatment plans for PCOS 
symptoms. Despite only 3.5% of those with PCOS in the OM cohort reporting use of 
supplements for PCOS symptoms, supplements can be used to treat symptoms as well as 
interact with metabolic pathways that lead to chronic comorbidities of PCOS such as 
diabetes, heart disease, and metabolic syndrome (Günalan et al., 2018).  
With additional research, medical personnel such as physicians and registered 
dietitians should consider adding supplements to treatment regimens for PCOS. Overall 
nutrition plays a crucial role in PCOS especially considering the higher risk of eating 
disorders in women with PCOS, therefore diet, exercise, and mental health should be 
included in treatment plan for PCOS. The future treatment and management of PCOS 
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